Pirfenidone (Esbriet): risk of serious liver injury; updated advice on liver function testing
Serious liver injury has been reported during treatment with pirfenidone in the first year after initiation, including two cases with a fatal outcome.
Please sign in or register for FREE
Sign in to OnMedica
Or sign in via